Ni Beibei, Sun Meijuan, Zhao Jun, Wang Jiao, Cao Zhanqi
Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China.
Front Pharmacol. 2023 Mar 22;14:1157043. doi: 10.3389/fphar.2023.1157043. eCollection 2023.
The Wnt/β-catenin signaling pathway is a classical Wnt pathway that regulates the stability and nuclear localization of β-catenin and plays an important role in adult heart development and cardiac tissue homeostasis. In recent years, an increasing number of researchers have implicated the dysregulation of this signaling pathway in a variety of cardiac diseases, such as myocardial infarction, arrhythmias, arrhythmogenic cardiomyopathy, diabetic cardiomyopathies, and myocardial hypertrophy. The morbidity and mortality of cardiac diseases are increasing, which brings great challenges to clinical treatment and seriously affects patient health. Thus, understanding the biological roles of the Wnt/β-catenin pathway in these diseases may be essential for cardiac disease treatment and diagnosis to improve patient quality of life. In this review, we summarize current research on the roles of β-catenin in human cardiac diseases and potential inhibitors of Wnt/β-catenin, which may provide new strategies for cardiac disease therapies.
Wnt/β-连环蛋白信号通路是一条经典的Wnt通路,它调节β-连环蛋白的稳定性和核定位,并在成年心脏发育和心脏组织稳态中发挥重要作用。近年来,越来越多的研究人员认为该信号通路的失调与多种心脏疾病有关,如心肌梗死、心律失常、致心律失常性心肌病、糖尿病性心肌病和心肌肥大。心脏病的发病率和死亡率不断上升,给临床治疗带来了巨大挑战,并严重影响患者健康。因此,了解Wnt/β-连环蛋白通路在这些疾病中的生物学作用,对于心脏病的治疗和诊断以提高患者生活质量可能至关重要。在这篇综述中,我们总结了目前关于β-连环蛋白在人类心脏病中的作用以及Wnt/β-连环蛋白潜在抑制剂的研究,这可能为心脏病治疗提供新策略。